Director of Process Innovation

Proclinical is partnering with a highly innovative biotechnology organization that is part of a leading global biopharmaceutical group. The company is at the cutting edge of next-generation in vivo cell and gene therapies, with a particular focus on novel lentiviral vector platforms designed to transform how therapies are delivered and manufactured. Combining the agility of a research-driven biotech with the scale and resources of a major pharmaceutical organization, this is a collaborative, science-first environment where creativity and technical excellence are encouraged, and where discovery work has a clear line of sight to patient impact. The Opportunity: Proclinical is seeking a Director, Process Innovation to lead discovery-stage process development and analytical innovation for an emerging lentiviral vector platform. This is a strategic leadership role focused on early-stage process design, platform building, and technical de-risking, rather than routine manufacturing or late-stage CMC. You will play a critical role in shaping how vectors are produced, characterized, and translated from bench to scalable bioreactor systems - creating the technical foundation that future CMC teams will build upon. This position can be based in Massachusetts, United States, Belgium or in Cambridgeshire, United Kingdom. Why This Role Matters: This is a rare opportunity to shape how future in vivo cell therapies are made - defining new technical standards, enabling innovative platforms, and accelerating the path from discovery to scalable therapies that could transform patient care.